antioxidant/infarction

FIELD OF THE INVENTION The present invention relates to a pyrazolidine derivative and, in particular, to a derivative effective as a radical scavenger in organisms. BACKGROUND OF THE INVENTION In recent years, attention has been paid to influences of active oxygen and free radical upon organisms.

RELATED APPLICATIONS None. FIELD OF THE INVENTION The present invention relates to a phenylenediamine derivative and, in particular, to a derivative effective as a radical scavenger in organisms. BACKGROUND OF THE INVENTION In recent years, attention has been paid to influences of active oxygen and

STATEMENT AS TO FEDERALLY SPONSORED RESEARCH Not applicable. FIELD OF THE INVENTION The invention relates generally to the fields of neurology, pharmaceuticals, and medicine. More particularly, the invention relates to the use of agents to protect brain tissue from ischemia/reperfusion

STATEMENT AS TO FEDERALLY SPONSORED RESEARCH Not applicable. FIELD OF THE INVENTION The invention relates generally to the fields of neurology, pharmaceuticals, and medicine. More particularly, the invention relates to the use of agents to protect brain tissue from ischemia/reperfusion

STATEMENT AS TO FEDERALLY SPONSORED RESEARCH Not applicable. FIELD OF THE INVENTION The invention relates generally to the fields of neurology, pharmaceuticals, and medicine. More particularly, the invention relates to the use of agents to protect brain tissue from ischemia/reperfusion

BACKGROUND OF THE INVENTION The present invention relates to use of alkylaryl polyether alcohol polymers as antioxidants to suppress certain oxidant chemical reactions that cause tissue injury and disease in mammals and plants. Oxygen is life-giving to aerobic plants and animals who depend on it for

This application is a 371 of PCT/JP93/01489 filed Oct. 18, 1993 and published as WO94/08930 Apr. 28, 1994. TECHNICAL FIELD This invention relates to compounds for preventing the oxidative modification of LDL, particularly, to compounds useful as therapeutics of arteriosclerosis, myocardial

TECHNICAL FIELD This invention relates to compounds for preventing the oxidative modification of LDL, particularly, to compounds useful as therapeutics of arteriosclerosis, myocardial infarction and other ischemic diseases. More specifically, the invention relates to compounds represented by the

TECHNICAL FIELD This invention relates to compounds for preventing the oxidative modification of LDL, particularly, to compounds useful as therapeutics of arteriosclerosis, myocardial infarction and other ischemic diseases. More specifically, the invention relates to compounds represented by the

TECHNICAL FIELD The present invention relates to a novel quinoline compound and a composition for the prevention and treatment of cardiovascular diseases containing the centipede extracts or compounds isolated therefrom. BACKGROUND ART Recently vascular disorder including atherosclerosis is rising

TECHNICAL FIELD The present invention relates to a novel quinoline compound and a composition for the prevention and treatment of cardiovascular diseases containing the centipede extracts or compounds isolated therefrom. BACKGROUND ART Recently vascular disorder including atherosclerosis is rising